Top Markets
Coin of the day
Agentix Corp. Agentix Corp.

Agentix Corp.

AGTX
Rank in Stocks #38793
Agentix Corp., a company in the clinical development phase, specializes in the... Agentix Corp., a company in the clinical development phase, specializes in the discovery and commercialization of therapeutic agents aimed at treating metabolic disorders. Its pipeline includes two primary candidates: AGTX-2004, a peripherally-acting CB1 receptor antagonist, which has exhibited effectiveness in animal studies for both obesity and type 2 diabetes mellitus; and AGTX-2003, a peripherally-acting CB1 receptor inverse agonist, also demonstrating positive results in animal models for obesity and non-alcoholic fatty liver diseases. The company was founded in 2013, initially known as FairWind Energy, Inc., before officially changing its name to Agentix Corp. in June 2019. Its operations are based in Dana Point, California.
Share Price
$0.02
Last synced: 2026-08-13
Market Cap
$801.34K
Change (1 day)
0.00%
Change (1 year)
-18.70%
Country
US
Trade Agentix Corp. (AGTX)

Category

Stock price history for Agentix Corp. (AGTX)
Highest end of day price: $0.02 on 2026-08-01

Lowest end of day price: $13.07 on 2015-08-01
Stock price history of Agentix Corp. from 2015 to 2026
Annual Stock Price Performance
Year Performance
2026 (TTM) -6.56%
2025 -78.30%
2024 515.58%
2023 -72.91%
2022 -82.45%
2021 61.22%
2020 -98.30%
2019 128.57%
2018 -65.57%
2017 13.66%
2016 21.09%
2015 0.00%
Stock price for similar companies or competitors
Company Stock price Change 1y% Country
$508.06 30.17%
US
$849.76 30.25%
NL
$731.69 7.13%
CH
$1.07K -6.40%
KR
$251.82 11.25%
BE